home / stock / ntus / ntus news

NTUS News and Press, Natus Medical Incorporated From 02/06/20

Stock Information
Company Name: Natus Medical Incorporated
Stock Symbol: NTUS
Market: NYSE
Website: natus.com
Menu
NTUS NTUS Quote NTUS Short NTUS News NTUS Articles NTUS Message Board
Get NTUS Alerts

News, Short Squeeze, Breakout and More Instantly...
NTUS - Natus Medical Announces Fourth Quarter and Full Year 2019 Financial Results

Fourth quarter revenue of $131.8 million Fourth quarter GAAP earnings per diluted share of $0.10 Fourth quarter non-GAAP earnings per diluted share of $0.46 Provides annual revenue and earnings guidance for 2020 PLEASANTON, Calif., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Natus Med...
NTUS - Natus Medical (NTUS) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

The following slide deck was published by Natus Medical Incorporated in conjunction with this Read more ...

NTUS - Natus Reaffirms Fourth Quarter 2019 Guidance and will Present at the 38th Annual JP Morgan Healthcare Conference

PLEASANTON, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for...

NTUS - Natus Medical to Hold 2019 Fourth Quarter Financial Results Conference Call on February 6th

PLEASANTON, Calif., Jan. 03, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders fo...
NTUS - Natus Medical Finalizes Transition of Peloton Business to Pediatrix Medical Group and Completes Signing of Strategic Agreement

PLEASANTON, Calif., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for ...

NTUS - Natus announces $50M share repurchase program

The Board of Directors of Natus Medical (NASDAQ: NTUS ) has authorized the repurchase of up to $50M of the Company's common stock through December 12, 2021. More news on: Natus Medical Incorporated, Healthcare stocks news, Stocks on the move, Read more ...

NTUS - Natus Announces $50 Million Share Repurchase Program

PLEASANTON, Calif., Dec. 17, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for...
NTUS - Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q3 2019 Results - Earnings Call Transcript

Natus Medical Incorporated (NTUS) Q3 2019 Earnings Conference Call October 24, 2019, 16:30 PM ET Company Participants Jonathan Kennedy - President and CEO Drew Davies - EVP and CFO Conference Call Participants Jayson Bedford - Raymond James Brian Weinstein - William Blair ...

NTUS - Natus Medical (NTUS) Q3 2019 Earnings Call Transcript

Image source: The Motley Fool. Natus Medical   (NASDAQ: NTUS) Q3 2019 Earnings Call Oct 24, 2019 , 4:30 p.m. ET Operator Continue reading

NTUS - Natus Medical EPS misses by $0.02, misses on revenue

Natus Medical (NASDAQ: NTUS ): Q3 Non-GAAP EPS of $0.36 misses by $0.02 ; GAAP EPS of $0.25 misses by $0.04 . More news on: Natus Medical Incorporated, Earnings news and commentary, Healthcare stocks news, Read more ...

Previous 10 Next 10